M. Kawasaki et al. / Journal of Molecular Catalysis B: Enzymatic 67 (2010) 135–142
139
chloride (0.07 g, 0.8 mmol), dry pyridine (0.108 g, 1.37 mmol)
and dry CH2Cl2 (3 mL) as a solvent according to the procedure
described in Section 4.4. Chromatography {silica gel, hexane/ethyl
acetate = 2:1 (v/v)} of the crude product afforded (RS)-5b (0.066 g,
51%) and 6b (0.028 g, 18%) as colorless oils.
(2H, t, J = 7.6), 1.78–1.87 (1H, m), 1.69 (2H, quintet, J = 7.8), 1.62 (2H,
quintet, J = 7.3), 1.25–1.45 (6H, m), 0.90 (3H, t, J = 6.9); 13C NMR:
174.50, 142.12, 128.36, 128.33, 125.80, 64.25, 62.66, 40.48, 36.02,
34.28, 31.30, 28.79, 27.42, 24.68, 22.29, 13.90; IR (neat): 3447,
1734 cm−1; MS (m/z) 292 (M+), 176 (base peak), 157, 145, 129, 117,
104, 91, 80, 71, 65, 55; HRMS calcd for C18H28O3 (M+), 292.2039.
Found: 292.2028.
(RS)-5b: 1H NMR: 7.26–7.29 (2H, m), 7.16–7.20 (3H, m), 4.20
(1H, dd, J = 4.4, J = 11.2), 4.09 (1H, dd, J = 6.6, J = 11.0), 3.58 (1H, dd,
J = 4.4, J = 11.2), 3.50 (1H, dd, J = 6.6, J = 11.4), 2.62 (2H, t, J = 7.6),
2.33 (2H, q, J = 7.6), 1.78–1.87 (1H, m), 1.69 (2H, quintet, J = 7.8),
1.29–1.45 (2H, m), 1.12 (3H, t, J = 7.6); 13C NMR: 175.10, 142.13,
128.37, 128.33, 125.80, 64.35, 62.63, 40.45, 36.01, 28.79, 27.58,
27.40, 9.17; IR (neat): 3446, 1737 cm−1; MS (m/z) 250 (M+), 232,
177 (base peak), 175, 157, 145, 130, 115, 103, 91, 80, 71, 65, 51;
HRMS calcd for C15H22O3 (M+), 250.1569. Found: 250.1603.
6b: 1H NMR: 7.26–7.29 (2H, m), 7.15–7.20 (3H, m), 4.08 (2H,
dd, J = 5.2, J = 11.2), 4.03 (2H, dd, J = 6.2, J = 11.0), 2.62 (2H, t, J = 7.6),
2.31 (4H, q, J = 7.5), 1.98–2.07 (1H, m), 1.69 (2H, quintet, J = 7.8),
1.37–1.43 (2H, m), 1.12 (6H, t, J = 7.4); 13C NMR: 174.43, 141.94,
128.36, 128.33, 125.83, 64.00, 37.22, 35.86, 28.47, 27.68, 27.52,
9.11; IR (neat): cm−1; MS (m/z) 306 (M+), 232 (base peak), 175,
159, 144, 129, 117, 104, 92, 65, 57; HRMS calcd for C18H26O4 (M+),
306.1831. Found: 306.1839
6d: 1H NMR: 7.26–7.29 (2H, m), 7.15–7.20 (3H, m), 4.08 (2H,
dd, J = 5.2, J = 11.2), 4.03 (2H, dd, J = 6.2, J = 11.0), 2.62 (2H, t, J = 7.6),
2.28 (4H, t, J = 7.4), 2.02 (1H, septet, J = 6.1), 1.68 (2H, quintet, J = 7.9),
1.60 (4H, quintet, J = 7.5), 1.24–1.42 (10H, m), 0.89 (6H, t, J = 6.9); 13
C
NMR: 173.97, 142.10, 128.50, 128.47, 125.97, 64.08, 37.35, 36.04,
34.38, 31.44, 28.64, 27.89, 24.77, 22.44, 14.05; IR (neat): 1738 cm−1
;
MS (m/z) 390 (M+), 275, 192 (base peak), 174, 158, 143, 129, 117,
104, 91, 80, 71, 65, 55; HRMS calcd for C24H38O4 (M+), 390.2770.
Found: 390.2771
4.8. 2-Methyl-5-phenyl-1-pentanol (Rosaphen®) (RS)-1
Racemic 2-methyl-5-phenyl-1-pentanol (Rosaphen®) (RS)-1
was prepared as an authentic sample. Dry THF (20 mL) and dry
diisopropylamine (5.125 g, 50.65 mmol) were added to a three-
necked, round-bottomed flask and maintained under an argon
atmosphere. After cooling the mixture to 0 ◦C, 2.6 mol/L n-butyl
lithium in hexane solution (19.5 mL, 51 mmol) was added via a
syringe over a period of 10 min. The mixture was stirred for 20 min
at 0 ◦C. A solution of propanoic acid (1.655 g, 22.34 mmol) in dry
THF (4.5 mL) was dropwise added over a period of 10 min. After
stirring for 10 min, dry HMPA (4.4 mL, 25 mmol) was introduced via
a syringe over a period of 10 min, and the mixture was stirred for
40 min at room temperature. 1-Bromo-3-phenylpropane (4.459 g,
22.40 mmol) dissolved in dry THF (4.467 g, 24.93 mmol) was drop-
wise added over the period of 15 min at 0 ◦C. After stirring overnight
at room temperature, the mixture was treated with 1 mol/L HCl
(60 mL) at 0 ◦C and extracted three times with ether. The ether
solution was washed with deionized water, saturated aqueous
sodium chloride, and dried with sodium sulfate. The solvent was
evaporated and the residue was chromatographed {silica gel, hex-
ane/acetone = 2:1 (v/v)} to give a colorless oil, which was distilled
(223–243 ◦C/0.9 mm Hg) to give 2-methyl-5-phenylpentanoic acid
(2.658 g, 62%); 1H NMR: 7.25–7.29 (2H, m), 7.16–7.19 (3H, m),
2.62 (2H, t, J = 7.6), 2.49 (1H, sextet, J = 6.9), 1.63–1.78 (3H, m),
1.44–1.53 (1H, m), 1.18 (3H, t, J = 6.8); 13C NMR: 182.92, 142.08,
128.37, 128.33, 125.80, 39.24, 35.74, 33.09, 28.95, 16.84; IR (neat):
1705 cm−1; MS (m/z) 192 (M+, base peak), 174, 131, 117, 104, 92, 87,
74, 65; HRMS calcd for C12H16O2 (M+), 192.1150. Found: 192.1149.
4.6. 2-Hydroxymethyl-5-phenylpentyl butanoate (RS)-5c and
2-butanoyloxymethyl-5-phenylpentyl butanoate 6c
samples were prepared from 4 (0.102 g, 0.525 mmol), butyryl
chloride (0.09 g, 0.8 mmol), dry pyridine (0.135 g, 1.71 mmol)
and dry CH2Cl2 (3 mL) as a solvent according to the procedure
described in Section 4.4. Chromatography {silica gel, hexane/ethyl
acetate = 2:1–1:1 (v/v)} of the crude product afforded (RS)-5c
(0.072 g, 52%) and 6c (0.030 g, 17%) as colorless oils.
(RS)-5c: 1H NMR: 7.26–7.30 (2H, m), 7.16–7.20 (3H, m), 4.22
(1H, dd, J = 4.4, J = 11.2), 4.09 (1H, dd, J = 6.4, J = 11.2), 3.59 (1H, dd,
J = 4.6, J = 11.4), 3.50 (1H, dd, J = 6.6, J = 11.4), 2.62 (2H, t, J = 7.4), 2.30
(2H, t, J = 7.4), 1.78–1.87 (1H, m), 1.60–1.73 (4H, m), 1.29–1.45 (2H,
m), 0.94 (3H, t, J = 7.4); 13C NMR: 174.32, 142.12, 128.37, 128.33,
125.80, 64.22, 62.66, 40.47, 36.19, 36.01, 28.79, 27.39, 18.48, 13.68;
IR (neat): 3449, 1734 cm−1; MS (m/z) 264 (M+), 176 (base peak),
159, 144, 129, 117, 104, 92, 77, 65, 57; HRMS calcd for C16H24O3
(M+), 264.1726. Found: 264.1720.
6c: 1H NMR: 7.26–7.29 (2H, m), 7.15–7.20 (3H, m), 4.08 (2H, dd,
J = 5.2, J = 11.2), 4.03 (2H, dd, J = 6.4, J = 11.2), 2.62 (2H, t, J = 7.6), 2.27
(4H, t, J = 7.4), 1.97–2.06 (1H, m), 1.58–1.72 (6H, m), 1.37–1.42 (2H,
m), 0.94 (3H, t, J = 7.4); 13C NMR: 173.64, 141.94, 128.36, 128.33,
125.82, 63.89, 37.20, 36.15, 35.88, 28.48, 27.70, 18.43, 13.67; IR
(neat): 1738 cm−1; MS (m/z) 334 (M+), 246 (base peak), 175, 159,
144, 129, 117, 104, 91, 83, 65, 57; HRMS calcd for C20H30O4 (M+),
334.2144. Found: 334.2142
A
solution of 2-methyl-5-phenylpentanoic acid (2.570 g,
13.37 mmol) in dry THF (20 mL) was added to a suspension of 80%
LiAlH4 (0.669 g, 14 mmol) in dry THF (15 mL) at 0 ◦C under an argon
atmosphere. The reaction mixture was stirred overnight at room
temperature and quenched at 0 ◦C with 1 mol/L HCl (60 mL). The
resulting mixture was extracted three times with ether. The organic
phase was washed with a saturated sodium chloride solution and
dried over sodium sulfate. After removal of the solvents, the residue
was chromatographed twice {silica gel, first: hexane/acetone = 2:1
(v/v), second: hexane/ethyl acetate = 2:1 (v/v)} to give a colorless
oil, which was distilled (187–208 ◦C/0.8 mm Hg) to give (RS)-1 as a
colorless oil (2.088 g, 88%). The 1H NMR spectra data were identical
to those in the literature [8].
4.7. 2-Hydroxymethyl-5-phenylpentyl hexanoate (RS)-5d and
2-hexanoyloxymethyl-5-phenylpentyl hexanoate 6d
samples were prepared from 4 (0.104 g, 0.535 mmol), hexanoyl
chloride (0.12 g, 0.89 mmol), dry pyridine (0.152 g, 1.92 mmol)
and dry CH2Cl2 (3 mL) as a solvent according to the procedure
described in Section 4.4. Chromatography {silica gel, hexane/ethyl
acetate = 2:1–1:1 (v/v)} of the crude product afforded (RS)-5d
(0.088 g, 57%) and 6d (0.066 g, 32%) as colorless oils.
4.9. 2-Methyl-5-phenylpentyl acetate (RS)-12
2-Methyl-5-phenylpentyl acetate (RS)-12 was prepared as an
authentic sample. Acetyl chloride (0.09 g, 1 mmol) was slowly
added to a solution of (RS)-1 (0.100 g, 0.561 mmol) and dry pyri-
dine (0.133 g, 1.68 mmol) in dry dichloromethane (5 mL) at 0 ◦C.
(RS)-5d: 1H NMR: 7.26–7.30 (2H, m), 7.16–7.20 (3H, m), 4.21
(1H, dd, J = 4.4, J = 11.2), 4.09 (1H, dd, J = 6.8, J = 11.2), 3.59 (1H, dd,
J = 4.6, J = 11.4), 3.50 (1H, dd, J = 6.6, J = 11.4), 2.62 (2H, t, J = 7.6), 2.31